Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “ARBUTUS BIOPHARMA CORPORATION”

56 pharma patents match "ARBUTUS BIOPHARMA CORPORATION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 56
Index total 30,257
Page 1 / 3

Quick answer

This filtered view shows 56 pharmaceutical patents matching "ARBUTUS BIOPHARMA CORPORATION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

56 results for “ARBUTUS BIOPHARMA CORPORATION” · 30,257 patents in full index Clear search

  1. US 12357705

    Negatively charged peg-lipid conjugates

    ARBUTUS BIOPHARMA CORPORATION · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  2. US 12350383

    Cationic lipids containing silicon

    ARBUTUS BIOPHARMA CORPORATION · Granted Jul 8, 2025 · Expires Jul 3, 2045

    granted
  3. US 12251470

    Lipid nanoparticle formulations

    ARBUTUS BIOPHARMA CORPORATION · Granted Mar 18, 2025 · Expires Mar 13, 2045

    granted
  4. US 12129467

    Non-liposomal systems for nucleic acid delivery

    ARBUTUS BIOPHARMA CORPORATION · Granted Oct 29, 2024 · Expires Oct 24, 2044

    granted
  5. US 12083118

    Substituted 1,1′-biphenyl compounds, analogues thereof, and methods using same

    ARBUTUS BIOPHARMA CORPORATION · Granted Sep 10, 2024 · Expires Sep 5, 2044

    granted
  6. US 12043833

    Targeted compositions

    ARBUTUS BIOPHARMA CORPORATION · Granted Jul 23, 2024 · Expires Jul 18, 2044

    granted
  7. US 12042541

    Lipids and compositions for the delivery of therapeutics

    ARBUTUS BIOPHARMA CORPORATION · Granted Jul 23, 2024 · Expires Jul 18, 2044

    granted
  8. US 12023383

    Lipid compositions

    ARBUTUS BIOPHARMA CORPORATION · Granted Jul 2, 2024 · Expires Jun 27, 2044

    granted
  9. US 12016929

    Lipid formulations for delivery of therapeutic agents

    ARBUTUS BIOPHARMA CORPORATION · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  10. US 11904052

    Methods for ameliorating infusion reactions

    ARBUTUS BIOPHARMA CORPORATION · Granted Feb 20, 2024 · Expires Feb 15, 2044

    granted
  11. US 11896672

    Targeted nucleic acid conjugate compositions

    ARBUTUS BIOPHARMA CORPORATION · Granted Feb 13, 2024 · Expires Feb 8, 2044

    granted
  12. US 11786598

    Lipid formulations for delivery of therapeutic agents

    ARBUTUS BIOPHARMA CORPORATION · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted
  13. US 11718852

    Non-liposomal systems for nucleic acid delivery

    ARBUTUS BIOPHARMA CORPORATION · Granted Aug 8, 2023 · Expires Aug 3, 2043

    granted
  14. US 11712476

    Lipids and compositions for the delivery of therapeutics

    ARBUTUS BIOPHARMA CORPORATION · Granted Aug 1, 2023 · Expires Jul 27, 2043

    granted
  15. US 11702427

    Substituted 2-pyridone tricyclic compounds, analogues thereof, and methods using same

    ARBUTUS BIOPHARMA CORPORATION · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted
  16. US 11566002

    Substituted tetrahydrocyclopenta[C]pyrroles, substituted dihydropyrrolizines, analogues thereof, and methods using same

    ARBUTUS BIOPHARMA CORPORATION · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  17. US 11505551

    Methods for preparing substituted pyridinone-containing tricyclic compounds

    ARBUTUS BIOPHARMA CORPORATION · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  18. US 11446383

    Lipid formulations for delivery of therapeutic agents

    ARBUTUS BIOPHARMA CORPORATION · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  19. US 11427823

    Targeted compositions

    ARBUTUS BIOPHARMA CORPORATION · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted
  20. US 11420931

    Lipid containing formulations

    ARBUTUS BIOPHARMA CORPORATION · Granted Aug 23, 2022 · Expires Aug 18, 2042

    granted
  21. US 11395854

    Trialkyl cationic lipids and methods of use thereof

    ARBUTUS BIOPHARMA CORPORATION · Granted Jul 26, 2022 · Expires Jul 21, 2042

    granted
  22. US 11351118

    Methods for ameliorating infusion reactions

    ARBUTUS BIOPHARMA CORPORATION · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  23. US 11318098

    Liposomal apparatus and manufacturing methods

    ARBUTUS BIOPHARMA CORPORATION · Granted May 3, 2022 · Expires Apr 28, 2042

    granted
  24. US 11298320

    Liposomal apparatus and manufacturing methods

    ARBUTUS BIOPHARMA CORPORATION · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted